Kogenate



Indications and Reactions:

Role Indications Reactions
Primary
Factor Viii Deficiency 36.7%
Drug Use For Unknown Indication 11.7%
Prophylaxis 7.8%
Haemophilia 7.0%
Postpartum Haemorrhage 4.7%
Haemorrhage 3.9%
Acquired Haemophilia 3.1%
Acute Coronary Syndrome 3.1%
Analgesia 3.1%
Procoagulant Therapy 3.1%
Diabetes Mellitus 2.3%
Hypertension 2.3%
Immune System Disorder 2.3%
Factor Viii Inhibition 1.6%
Haemarthrosis 1.6%
Haemorrhage Prophylaxis 1.6%
Tooth Extraction 1.6%
Angiogram 0.8%
Haemophilic Arthropathy 0.8%
Pilonidal Sinus Repair 0.8%
Haematoma 13.6%
Haemorrhage 13.6%
Factor Viii Inhibition 10.2%
Haemorrhagic Diathesis 8.5%
Intracranial Haematoma 8.5%
Pneumonia 6.8%
Human Anti-mouse Antibody Positive 5.1%
Injection Site Urticaria 5.1%
Acute Myocardial Infarction 3.4%
Hepatic Neoplasm Malignant 3.4%
Pain 3.4%
Post Procedural Haemorrhage 3.4%
Venous Thrombosis Limb 3.4%
Anti Factor Viii Antibody Positive 1.7%
Arthralgia 1.7%
Cardiac Operation 1.7%
Chest Pain 1.7%
Drug Tolerance 1.7%
Haemarthrosis 1.7%
Haemophilia 1.7%
Secondary
Factor Viii Deficiency 37.6%
Prophylaxis 11.3%
Immune System Disorder 10.7%
Drug Use For Unknown Indication 6.9%
Factor Viii Inhibition 6.6%
Diabetes Mellitus 4.9%
Haemophilia 4.9%
Haemorrhage 2.8%
Haemostasis 2.0%
Immune Tolerance Induction 2.0%
Postpartum Haemorrhage 1.5%
Haemarthrosis 1.3%
Surgery 1.3%
Wound Infection 1.3%
Acquired Haemophilia 1.0%
Acute Coronary Syndrome 1.0%
Hepatitis C 1.0%
Hypertension 0.8%
Haemorrhage Prophylaxis 0.5%
Tooth Extraction 0.5%
Injection Site Urticaria 13.2%
Factor Viii Inhibition 12.7%
Haematoma 12.7%
Venous Thrombosis Limb 12.7%
Human Anti-mouse Antibody Positive 10.7%
Haemorrhage 10.2%
Venous Thrombosis 7.8%
Haemorrhage Subcutaneous 7.3%
Intracranial Haematoma 4.4%
Cardiac Operation 2.4%
Arthralgia 1.0%
Post Procedural Haemorrhage 1.0%
Haemarthrosis 0.5%
Haemorrhagic Diathesis 0.5%
Malaise 0.5%
Product Quality Issue 0.5%
Respiratory Failure 0.5%
Sudden Death 0.5%
Unresponsive To Stimuli 0.5%
Urticaria 0.5%
Concomitant
Hiv Infection 52.0%
Hepatitis C 11.5%
Product Used For Unknown Indication 6.9%
Haemophilia 6.7%
Factor Viii Deficiency 3.4%
Gastritis 3.4%
Drug Use For Unknown Indication 3.2%
Chronic Hepatitis C 2.5%
Coagulopathy 1.6%
Acquired Immunodeficiency Syndrome 1.4%
Haemarthrosis 1.1%
Pain 1.1%
Osteoporosis 0.9%
Arthralgia 0.7%
Hepatic Cirrhosis 0.7%
Infection Prophylaxis 0.7%
Pneumocystis Jiroveci Pneumonia 0.7%
Bronchopulmonary Aspergillosis 0.5%
Diarrhoea 0.5%
Hypertension 0.5%
Haemorrhage 16.1%
Liver Function Test Abnormal 16.1%
Hepatic Cirrhosis 11.3%
Arthritis Bacterial 8.1%
Pancytopenia 6.5%
Renal Impairment 4.8%
Renal Tubular Disorder 4.8%
Urinary Sediment Abnormal 4.8%
Death 3.2%
Drug Ineffective 3.2%
Gastrointestinal Haemorrhage 3.2%
Haemarthrosis 3.2%
Osteonecrosis 3.2%
Anastomotic Haemorrhage 1.6%
Factor Viii Inhibition 1.6%
Hyperthermia 1.6%
Primary Hypothyroidism 1.6%
Sepsis 1.6%
Shock Haemorrhagic 1.6%
Small Intestine Carcinoma 1.6%